MYRIAD GENETICS INC Total Revenue

• MYRIAD GENETICS INC showed a decrease of -1.6% in Total Revenue from 2024 to 2025.
• This data is from MYRIAD GENETICS INC's annual report (Form 10-K), filed with the SEC on February 24, 2026.
• XBRL data for this metric is available from 2009 to 2025 (21 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q1 2013: $156.47 million | Q3 2013: $202.47 million | Q4 2013: $204.06 million | Q1 2014: $182.92 million | Q3 2014: $168.80 million | Q4 2014: $184.40 million | Q1 2015: $180.00 million | Q3 2015: $183.50 million | Q4 2015: $193.30 million | Q1 2016: $190.50 million | Q3 2016: $177.50 million | Q3 2016: $178.90 million | Q4 2016: $196.50 million | Q4 2016: $196.70 million | Q1 2017: $196.90 million | Q1 2017: $194.70 million | Q2 2017: $199.60 million | Q3 2017: $190.20 million | Q3 2017: $178.80 million | Q4 2017: $194.00 million | Q4 2017: $187.90 million | Q1 2018: $193.50 million | Q1 2018: $183.10 million | Q2 2018: $193.90 million | Q3 2018: $202.30 million | Q4 2018: $216.80 million | Q1 2019: $216.60 million | Q2 2019: $215.40 million | Q3 2019: $186.30 million | Q4 2019: $195.10 million | Q1 2020: $164.00 million | Q2 2020: $93.20 million | Q3 2020: $145.20 million | Q1 2021: $173.10 million | Q2 2021: $189.40 million | Q3 2021: $167.30 million | Q1 2022: $164.90 million | Q2 2022: $179.30 million | Q3 2022: $156.40 million | Q1 2023: $181.20 million | Q2 2023: $183.50 million | Q3 2023: $191.90 million | Q1 2024: $202.20 million | Q2 2024: $211.50 million | Q3 2024: $213.30 million | Q1 2025: $195.90 million | Q2 2025: $213.10 million | Q3 2025: $205.70 million.
• Over the full 21 years of available data (2009 to 2025), MYRIAD GENETICS INC's Total Revenue has grown by 152.5%.
• Historical annual values: Fiscal year 2025: $824.50 million | Fiscal year 2024: $837.60 million | Fiscal year 2023: $753.20 million | Fiscal year 2022: $678.40 million | Fiscal year 2021: $690.60 million | Fiscal year 2020: $557.10 million | Fiscal year 2020: $638.60 million | Fiscal year 2019: $851.10 million | Fiscal year 2018: $743.70 million | Fiscal year 2017: $728.70 million | Fiscal year 2017: $771.40 million | Fiscal year 2016: $740.50 million | Fiscal year 2016: $753.80 million | Fiscal year 2015: $722.50 million | Fiscal year 2015: $723.10 million | Fiscal year 2014: $778.20 million | Fiscal year 2013: $613.20 million | Fiscal year 2012: $496.01 million | Fiscal year 2011: $402.08 million | Fiscal year 2010: $362.65 million | Fiscal year 2009: $326.53 million.
• Data sourced from SEC EDGAR public filings as of August 9, 2026.

Last verified: August 9, 2026